1Hachinski VC, Iliff LD, Zilhka E, et at. Cerebral blood flow in dementia [ J ]. Arch Neurol, 1975,32 (9) :632-637.
2Economos A, Wright CB, Moon YP, et at. Interlenkin 6 plasma concen- tration associates with cognitive decline:the northern Manhattan study [ J ]. Neuroepidemiology, 2013,40 ( 4 ) : 253-259.
3Mohamed NE, Zhao Y, Lee JH, et al. Upregulation of AMPA receptor GIuR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer' s disease [ J ]. Neurochem Int, 2011,58 (7) : 820-825.
5Mansoori N,Tripathi M, Luthra K, et al. MTHFR ( 677 and 1298 ) and IL-6-174 G/C genes in pathogenesis of Alzheimer' s and vascular de- mentia and their epistatic interaction [ J ]. Neurobiol Aging, 2012,33 (5) :1003. el-8.
6Staekenborg SS,van Straaten ECW ,van tier Flier WM, et a~. Small ves- sel versus large vessel vascular dementia:risk factors and MRI findings [ J ]. J Neuro1,2008,255 ( 11 ) : 1644-1651 ; discussion 1813-1814.
7Lawrence AJ, Patel B, Morris RG, et al. Mechanisms of cognitive im- pairment in cerebral small vessel disease:multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study [J]. PLoS One,2013,8(4) :e61014.
8Nitkunan A, Barrick TR, Charhon RA, et al. Mu|timodal MR1 in cere- bral small vessel disease:its relationship with cognition and sensitivity to change over time[ J]. Stroke,2008,39(7 ) : 1999-2005.
9Biesbroek JM, Kuijf HJ, van der Graaf Y, et al. Association between subcortical vascular lesion location and cognition: a voxel-based and tract-based lesion-symptom mapping study. The SMART-MR study [ J ]. PLoS One,2013,8(4) :e60541.
10Panczykowski DM, Monaco EA 3rd, Friedlander RM. Connectivity fea- tures for identifying cognitive impairment in presymptomatic carotid ste- nosis[ J]. Neurosurgery,2014,74(4) :N9 - Nil.
8Hansen TW, Thijs I, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 popula- tions. Hypertension ,2010,55 : 1049-1057.
